Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

295 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Progress in the treatment of acute myeloid leukemia.
Ravandi F, Burnett AK, Agura ED, Kantarjian HM. Ravandi F, et al. Among authors: burnett ak. Cancer. 2007 Nov 1;110(9):1900-10. doi: 10.1002/cncr.23000. Cancer. 2007. PMID: 17786921 Review.
Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council.
Hann IM, Stevens RF, Goldstone AH, Rees JK, Wheatley K, Gray RG, Burnett AK. Hann IM, et al. Among authors: burnett ak. Blood. 1997 Apr 1;89(7):2311-8. Blood. 1997. PMID: 9116274 Clinical Trial.
Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.
Grimwade D, Gorman P, Duprez E, Howe K, Langabeer S, Oliver F, Walker H, Culligan D, Waters J, Pomfret M, Goldstone A, Burnett A, Freemont P, Sheer D, Solomon E. Grimwade D, et al. Blood. 1997 Dec 15;90(12):4876-85. Blood. 1997. PMID: 9389704
A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council.
Langabeer SE, Grimwade D, Walker H, Rogers JR, Burnett AK, Goldstone AH, Linch DC. Langabeer SE, et al. Among authors: burnett ak. Br J Haematol. 1998 May;101(2):338-40. doi: 10.1046/j.1365-2141.1998.00686.x. Br J Haematol. 1998. PMID: 9609531
Transplantation in first remission of acute myeloid leukemia.
Burnett AK. Burnett AK. N Engl J Med. 1998 Dec 3;339(23):1698-700. doi: 10.1056/NEJM199812033392309. N Engl J Med. 1998. PMID: 9834309 No abstract available.
Tailoring the treatment of acute myeloid leukemia.
Burnett AK. Burnett AK. Curr Opin Oncol. 1999 Jan;11(1):14-9. doi: 10.1097/00001622-199901000-00004. Curr Opin Oncol. 1999. PMID: 9914872 Review.
Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial.
Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH. Burnett AK, et al. Blood. 1999 Jun 15;93(12):4131-43. Blood. 1999. PMID: 10361110 Clinical Trial.
Tailoring the treatment of acute myeloid leukemia.
Burnett AK. Burnett AK. Curr Opin Hematol. 1999 Jul;6(4):247-52. doi: 10.1097/00062752-199907000-00009. Curr Opin Hematol. 1999. PMID: 10400374 Review.
Acute myeloid leukemia.
Löwenberg B, Downing JR, Burnett A. Löwenberg B, et al. N Engl J Med. 1999 Sep 30;341(14):1051-62. doi: 10.1056/NEJM199909303411407. N Engl J Med. 1999. PMID: 10502596 Review. No abstract available.
Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial.
Watson M, Wheatley K, Harrison GA, Zittoun R, Gray RG, Goldstone AH, Burnett AK. Watson M, et al. Among authors: burnett ak. Cancer. 1999 Oct 1;86(7):1231-9. doi: 10.1002/(sici)1097-0142(19991001)86:7<1231::aid-cncr18>3.0.co;2-y. Cancer. 1999. PMID: 10506708 Clinical Trial.
295 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback